Latest news

Posts by eXoZymes

Lightning Rx, Colette Nataf

Podcast: Lightning Rx' Colette Nataf interviews CEO Heltzen on future of biomanufacturing

Podcast: 'The Catalyst' interviews CEO, Michael Heltzen

Zachary Karl, Vice President Business Development @ Bio Innovations Midwest 2025

World Bio Markets: AI - A tool U.S. industrial biomanufacturing cannot ignore

Inside Biotech podcast interviews CEO, Michael Heltzen

Podcast: 'Inside Biotech' interviews CEO, Michael Heltzen

CCO Damien Perriman and co-founder and VP of Development, Dr. Paul Opgenorth.

Driving the cell-free revolution: eXoZymes leaders join BioMADE Leadership & Technical Committees

MDB Capital: eXoZymes & NCTx: The Breakthrough Opportunity with NCTx and Treating a Global Health Epidemic

The challenges of SynBio

Transcript: Q2 2025 Earnings Call

eXoZymes provides second quarter 2025 update at 5PM EST today

eXoZymes to host second quarter 2025 update on Tuesday August 12, 2025, at 5PM EST